Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg’s global leadership in business and financial news and data, with Quintillion Media’s deep expertise in the Indian market and digital news delivery, to provide high quality business news, insights and trends for India’s sophisticated audiences.
(Bloomberg) -- Investors looking to bet against a strong start to sales of Aimmune Therapeutics Inc.’s peanut allergy medicine should proceed with caution, according to Piper Jaffray.